| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 2810.81 | 98 |
| GSM780708 | Untreated after 4 days (C2_1) | 2366.84 | 98 |
| GSM780709 | Untreated after 4 days (C3_1) | 1757.14 | 98 |
| GSM780719 | Untreated after 4 days (C1_2) | 2644.09 | 98 |
| GSM780720 | Untreated after 4 days (C2_2) | 2394.89 | 98 |
| GSM780721 | Untreated after 4 days (C3_2) | 1991.26 | 98 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 1707.47 | 97 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 2565.45 | 98 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 2549.45 | 98 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 1867.69 | 98 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 2869.79 | 98 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 2777.13 | 98 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 2298.23 | 98 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 2055.22 | 98 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 2668.32 | 98 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 2807.93 | 98 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 2291.05 | 98 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 2633.07 | 98 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 2766.77 | 98 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 2471.62 | 98 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 2338.34 | 98 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 2792.26 | 98 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 2716.11 | 98 |